Alzheimer's disease clinical and research update for health care practitioners

Journal of Aging Research

Volumn 2013, Issue , 2013, Pages

  Defina, Philip A ^a   Moser, Rosemarie Scolaro ^b   Glenn, Megan ^b   Lichtenstein, Jonathan D ^b   Fellus, Jonathan ^a  

^a International Brain Research Foundation   (United States)

^b RSM Psychology Center LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CHOLINE; CHOLINESTERASE INHIBITOR; CURCUMIN; DONEPEZIL; GALANTAMINE; GLYCEROPHOSPHORYLCHOLINE; HUPERZINE A; IMMUNOGLOBULIN; INSULIN; MEMANTINE; PHOSPHATIDYLSERINE; PRESENILIN 1; PRESENILIN 2; PSYCHOTROPIC AGENT; RIVASTIGMINE; VITAMIN D;

AEROBIC EXERCISE; AGING; ALZHEIMER DISEASE; CELL PROLIFERATION; CLINICAL RESEARCH; COMORBIDITY; DIAGNOSTIC APPROACH ROUTE; DIET SUPPLEMENTATION; EPISODIC MEMORY; EXTRAPYRAMIDAL SYNDROME; GENE MUTATION; HEALTH CARE PERSONNEL; HUMAN; INTERVENTION STUDY; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROFEEDBACK; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; PARENT COUNSELING; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SEMANTIC MEMORY; SUPPORT GROUP; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84884856741     PISSN: 20902204     EISSN: 20902212     Source Type: Journal    
DOI: 10.1155/2013/207178     Document Type: Review

References (50)

1. NINDS, Dementia: hope through research. 2012, http://www.ninds.nih.gov/ disorders/dementias/detail-dementia.html
2. CDC, Alzheimer's disease. 2010, http://www.cdc.gov/Features/Alzheimers/ index.html
3. Weintraub S., Wicklund A. H., Salmon D. P., The neuropsychological profile of Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012 2 4 a006171 10.1101/cshperspect.a006171
4. Burns J. M., Morris J. C., Mild Cognitive Impairment and Early Alzheimer's Disease: Detections and Diagnosis 2008 John Wiley & Sons
5. Bondi M. W., Salmon D. P., Kaszniak A. W., Grant I., Adams K., The neuropsychology of dementia. Neuropsychological Assessment of Neuropsychiatric and Neuromedical Disorders 2009 New York, NY, USA Oxford University Press 159 198
6. Jack C. R. Jr., Albert M. S., Knopman D. S., McKhann G. M., Sperling R. A., Carrillo M. C., Thies B., Phelps C. H., Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia 2011 7 3 257 262 2-s2.0-79956076567 10.1016/j.jalz.2011.03.004
7. Petersen R. C., Petersen R. C., Conceptual overview. Mild Cognitive Impairment: Aging to Alzheimer's Disease 2003 New York, NY, USA Oxford University Press 1 14
8. Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., Gamst A., Holtzman D. M., Jagust W. J., Petersen R. C., Snyder P. J., Carrillo M. C., Thies B., Phelps C. H., The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia 2011 7 3 270 279 2-s2.0-79956084514 10.1016/j.jalz.2011.03.008
9. Association As, Alzheimer's disease facts and figures. 2012, http://www.alz.org/downloads/facts-figures-2012.pdf
10. NIA, 2011-2012 Alzheimer's Disease Progress Report: Intensifying the Research Effort 2012
11. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991 82 4 239 259 2-s2.0-0025863618
12. Selkoe D. J., The molecular pathology of Alzheimer's disease. Neuron 1991 6 4 487 498 2-s2.0-0025753852 10.1016/0896-6273(91)90052-2
13. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002 297 5580 353 356 2-s2.0-0037135111 10.1126/science.1072994 (Pubitemid 34790756)
14. Hoffman J., The Alzheimer's Project: Momentum in Science 2009 New York, NY, USA PublicAffairs/Home Box Office
15. Nagy Z., Yilmazer-Hanke D. M., Braak H., Braak E., Schultz C., Hanke J., Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: a comparative study. Dementia and Geriatric Cognitive Disorders 1998 9 3 140 144 2-s2.0-0031896446 10.1159/000017038 (Pubitemid 28171885)
16. McKhann G. M., Knopman D. S., Chertkow H., Hyman B. T., Jack C. R. Jr., Kawas C. H., Klunk W. E., Koroshetz W. J., Manly J. J., Mayeux R., Mohs R. C., Morris J. C., Rossor M. N., Scheltens P., Carrillo M. C., Thies B., Weintraub S., Phelps C. H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia 2011 7 3 263 269 2-s2.0-79956142378 10.1016/j.jalz.2011.03.005
17. Klunk W. E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D. P., Bergström M., Savitcheva I., Huang G.-F., Estrada S., Ausén B., Debnath M. L., Barletta J., Price J. C., Sandell J., Lopresti B. J., Wall A., Koivisto P., Antoni G., Mathis C. A., Långström B., Imaging brain amyloid in Alzheimer's disease with pittsburgh compound-B. Annals of Neurology 2004 55 3 306 319 2-s2.0-10744232413 10.1002/ana.20009 (Pubitemid 38269583)
18. Trojanowski J. Q., Vandeerstichele H., Korecka M., Clark C. M., Aisen P. S., Petersen R. C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W. Z., Weiner M. W., Jack C. R. Jr., Jagust W., Toga A. W., Lee V. M.-Y., Shaw L. M., Update on the biomarker core of the Alzheimer's disease neuroimaging initiative subjects. Alzheimer's and Dementia 2010 6 3 230 238 2-s2.0-77955483685 10.1016/j.jalz.2010.03.008
19. Jagust W., Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia. Alzheimer's and Dementia 2006 2 1 36 42 2-s2.0-33144484369 10.1016/j.jalz.2005.11.002 (Pubitemid 43264482)
20. Atiya M., Hyman B. T., Albert M. S., Killiany R., Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review. Alzheimer Disease and Associated Disorders 2003 17 3 177 195 2-s2.0-0141817988 10.1097/00002093-200307000-00010 (Pubitemid 37205710)
21. APA, Diagnostic and Statistical Manual of Mental Disorders 2000 4th Washington, DC, USA American Psychiatric Association
22. Warren J. D., Fletcher P. D., Golden H. L., The paradox of syndromic diversity in Alzheimer disease. Nature Reviews 2012 8 8 451 464 10.1038/nrneurol.2012.135
23. Lezak M. D., Neuropsychological Assessment 2012 5th New York, NY, USA Oxford University Press
24. Malamut B. L., Ryan L. M., Sirven J. I., Malamut B. L., Dementia: behavioral and cognitive aspectseds. Clinical Neurology of the Older Adult 2008 2nd Philadelphia, Pa, USA Wolters Kluwer Health/Lippincott Williams & Wilkins 318 338
25. Mitrushina M., Grant I., Adams K., Cognitive screening methods. Neuropsychological Assessment of Neuropsychiatric and Neuromedical Disorders 2009 New York, NY, USA Oxford University Press 101 126
26. Nasreddine Z. S., Phillips N. A., Bédirian V., Charbonneau S., Whitehead V., Collin I., Cummings J. L., Chertkow H., The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 2005 53 4 695 699 2-s2.0-18944374033 10.1111/j.1532-5415.2005.53221.x (Pubitemid 41623495)
27. Weintraub S., Salmon D., Mercaldo N., Ferris S., Graff-Radford N. R., Chui H., Cummings J., DeCarli C., Foster N. L., Galasko D., Peskind E., Dietrich W., Beekly D. L., Kukull W. A., Morris J. C., The Alzheimer's disease denters' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Disease and Associated Disorders 2009 23 2 91 101 2-s2.0-67651068689 10.1097/WAD. 0b013e318191c7dd
28. Freedman M., Clock Drawing: A Neuropsychological Analysis 1994 Oxford University Press
29. Morris J. C., Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. International Psychogeriatrics 1997 9 supplement 1 173 176 2-s2.0-0031438475 10.1017/S1041610297004870 (Pubitemid 28045357)
30. O'Bryant S. E., Lacritz L. H., Hall J., Waring S. C., Chan W., Khodr Z. G., Massman P. J., Hobson V., Cullum C. M., Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database. Archives of Neurology 2010 67 6 746 749 2-s2.0-77953630113 10.1001/archneurol.2010.115
31. Association As, Current Alzheimer's Treatments 2013
32. Herrmann N., Chau S. A., Kircanski I., Lanctôt K. L., Current and emerging drug treatment options for Alzheimers disease: a systematic review. Drugs 2011 71 15 2031 2065 2-s2.0-80053971718 10.2165/11595870-000000000-00000
33. Tariot P. N., Farlow M. R., Grossberg G. T., Graham S. M., McDonald S., Gergel I., Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. Journal of the American Medical Association 2004 291 3 317 324 2-s2.0-0345872128 10.1001/jama.291.3.317 (Pubitemid 38101604)
34. Duara R., Barker W., Loewenstein D., Bain L., The basis for disease-modifying treatments for Alzheimer's disease: the sixth snnual mild cognitive impairment symposium. Alzheimer's and Dementia 2009 5 1 66 74 2-s2.0-58049134412 10.1016/j.jalz.2008.10.006
35. Relkin N., Bettger L., Tsakanikas D., Ravdin L., Three year follow-up on the IVIG for Alzheimer's phase II study. Alzheimer's & Dementia 2012 8 4, article 589
36. Craft S., Baker L. D., Montine T. J., Minoshima S., Watson G. S., Claxton A., Arbuckle M., Callaghan M., Tsai E., Plymate S. R., Green P. S., Leverenz J., Cross D., Gerton B., Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of Neurology 2012 69 1 29 38 2-s2.0-84855613853 10.1001/archneurol.2011.233
37. Venneri A., McGeown W. J., Shanks M. F., Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease. Neuroreport 2005 16 2 107 110 2-s2.0-13844251864 10.1097/00001756-200502080- 00006 (Pubitemid 40250379)
38. Howard R., McShane R., Lindesay J., Ritchie C., Baldwin A., Barber R., Burns A., Dening T., Findlay D., Holmes C., Hughes A., Jacoby R., Jones R., Jones R., McKeith I., Macharouthu A., O'Brien J., Passmore P., Sheehan B., Juszczak E., Katona C., Hills R., Knapp M., Ballard C., Brown R., Banerjee S., Onions C., Griffin M., Adams J., Gray R., Johnson T., Bentham P., Phillips P., Donepezil and memantine for moderate-to-severe Alzheimer's disease. The New England Journal of Medicine 2012 366 10 893 903 2-s2.0-84857843877 10.1056/NEJMoa1106668
39. Thaipisuttikul P., Galvin J. E., Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease. Clinical Practice 2012 9 2 199 209 2-s2.0-84858034620 10.2217/cpr.12.3
40. Hong L., Translational research in neurology: dementia. Archives of Neurology 2012 69 8 969 977
41. Wu Q., Xuan W., Ando T., Xu T., Huang L., Huang Y.-Y., Dai T., Dhital S., Sharma S. K., Whalen M. J., Hamblin M. R., Low-level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths. Lasers in Surgery and Medicine 2012 44 3 218 226 2-s2.0-84859077020 10.1002/lsm.22003
42. Hu W.-P., Wang J.-J., Yu C.-L., Lan C.-C. E., Chen G.-S., Yu H.-S., Helium-neon laser irradiation stimulates cell proliferation through photostimulatory effects in mitochondria. Journal of Investigative Dermatology 2007 127 8 2048 2057 2-s2.0-34447580005 10.1038/sj.jid.5700826 (Pubitemid 47075379)
43. Sommer A. P., Bieschke J., Friedrich R. P., Zhu D., Wanker E. E., Fecht H. J., Mereles D., Hunstein W., 670 nm laser light and EGCG complementarily reduce amyloid- β aggregates in human neuroblastoma cells: basis for treatment of alzheimer's disease? Photomedicine and Laser Surgery 2012 30 1 54 60 2-s2.0-84855419227 10.1089/pho.2011.3073
44. Sadowsky C. H., Galvin J. E., Guidelines for the management of cognitive and behavioral problems in dementia. Journal of the American Board of Family Medicine 2012 25 3 350 366 10.3122/jabfm.2012.03.100183
45. National Institute on Aging NIoH, Department of Health and Human Services, Preventing Alzheimer's Disease: What Do We Know? 2012
46. Voss M. W., Erickson K. I., Prakash R. S., Neurobiological markers of exercise-related brain plasticity in older adults. Brain, Behavior, and Immunity 2013 28 90 99
47. Heyn P., Abreu B. C., Ottenbacher K. J., The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Archives of Physical Medicine and Rehabilitation 2004 85 10 1694 1704 2-s2.0-5344237365 10.1016/j.apmr.2004.03.019 (Pubitemid 39349417)
48. Scarmeas N., Stern Y., Tang M.-X., Mayeux R., Luchsinger J. A., Mediterranean diet and risk for Alzheimer's disease. Annals of Neurology 2006 59 6 912 921 2-s2.0-33744807433 10.1002/ana.20854 (Pubitemid 43830923)
49. Wilson R. S., Bennett D. A., Bienias J. L., Aggarwal N. T., De Leon C. F. M., Morris M. C., Schneider J. A., Evans D. A., Cognitive activity and incident AD in a population-based sample of older persons. Neurology 2002 59 12 1910 1914 2-s2.0-0037168799 (Pubitemid 36076563)
50. Karp A., Paillard-Borg S., Wang H.-X., Silverstein M., Winblad B., Fratiglioni L., Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dementia and Geriatric Cognitive Disorders 2006 21 2 65 73 2-s2.0-30844436811 10.1159/000089919 (Pubitemid 43107131)